| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capsid Proteins | 11 | 2015 | 60 | 1.340 |
Why?
|
| Oncogene Proteins, Viral | 10 | 2015 | 25 | 1.280 |
Why?
|
| Papillomavirus Vaccines | 8 | 2015 | 136 | 1.090 |
Why?
|
| Acetyltransferases | 4 | 2004 | 26 | 0.990 |
Why?
|
| Papillomavirus Infections | 10 | 2015 | 316 | 0.950 |
Why?
|
| Histone Acetyltransferases | 6 | 2007 | 18 | 0.850 |
Why?
|
| Transcription Factors | 6 | 2018 | 653 | 0.760 |
Why?
|
| Papillomaviridae | 7 | 2012 | 125 | 0.750 |
Why?
|
| Cell Cycle Proteins | 3 | 2007 | 220 | 0.710 |
Why?
|
| Human papillomavirus 16 | 7 | 2013 | 34 | 0.610 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 117 | 0.530 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2017 | 84 | 0.510 |
Why?
|
| Enzyme Inhibitors | 6 | 2010 | 396 | 0.510 |
Why?
|
| Histones | 4 | 2009 | 177 | 0.500 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2019 | 63 | 0.480 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 794 | 0.470 |
Why?
|
| Drug Discovery | 1 | 2014 | 77 | 0.470 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 117 | 0.460 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 286 | 0.440 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 303 | 0.430 |
Why?
|
| Animals | 29 | 2023 | 14307 | 0.420 |
Why?
|
| Mice | 20 | 2023 | 5668 | 0.410 |
Why?
|
| Adjuvants, Immunologic | 4 | 2015 | 106 | 0.400 |
Why?
|
| Transcription, Genetic | 5 | 2019 | 550 | 0.400 |
Why?
|
| Chromatin | 4 | 2023 | 164 | 0.390 |
Why?
|
| Hela Cells | 6 | 2014 | 344 | 0.390 |
Why?
|
| Humans | 41 | 2024 | 34853 | 0.390 |
Why?
|
| Repressor Proteins | 4 | 2015 | 226 | 0.390 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 33 | 0.380 |
Why?
|
| Antibodies, Viral | 8 | 2015 | 252 | 0.380 |
Why?
|
| Saponins | 2 | 2015 | 5 | 0.380 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 3 | 0.370 |
Why?
|
| Ellagic Acid | 1 | 2009 | 4 | 0.370 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2010 | 248 | 0.370 |
Why?
|
| Arginine | 1 | 2009 | 62 | 0.360 |
Why?
|
| Molecular Sequence Data | 7 | 2009 | 1490 | 0.340 |
Why?
|
| Amino Acid Sequence | 6 | 2009 | 1124 | 0.330 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2007 | 2 | 0.310 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 1426 | 0.300 |
Why?
|
| Trans-Activators | 2 | 2005 | 167 | 0.300 |
Why?
|
| Female | 28 | 2023 | 19873 | 0.300 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 203 | 0.290 |
Why?
|
| Kinetics | 4 | 2014 | 650 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 781 | 0.280 |
Why?
|
| Neoplasms | 4 | 2019 | 1033 | 0.270 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 287 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 184 | 0.270 |
Why?
|
| Acetylation | 4 | 2007 | 94 | 0.270 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 2128 | 0.260 |
Why?
|
| Neutralization Tests | 6 | 2013 | 53 | 0.260 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2016 | 32 | 0.250 |
Why?
|
| Anacardic Acids | 2 | 2005 | 2 | 0.250 |
Why?
|
| Terpenes | 1 | 2004 | 28 | 0.250 |
Why?
|
| Curcumin | 1 | 2004 | 66 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 383 | 0.240 |
Why?
|
| Prostatic Hyperplasia | 1 | 2024 | 33 | 0.240 |
Why?
|
| Metabolome | 3 | 2019 | 47 | 0.230 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 756 | 0.230 |
Why?
|
| Salicylates | 1 | 2003 | 7 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 968 | 0.230 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 11 | 0.230 |
Why?
|
| Virion | 3 | 2012 | 67 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 106 | 0.230 |
Why?
|
| Mice, Nude | 4 | 2021 | 323 | 0.230 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 32 | 0.230 |
Why?
|
| Receptors, Calcitriol | 1 | 2023 | 59 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 7 | 2015 | 649 | 0.220 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 91 | 0.220 |
Why?
|
| Quinolines | 1 | 2022 | 60 | 0.210 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2007 | 10 | 0.210 |
Why?
|
| Benzylidene Compounds | 1 | 2021 | 5 | 0.210 |
Why?
|
| Models, Molecular | 4 | 2010 | 751 | 0.190 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 197 | 0.190 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 14 | 0.190 |
Why?
|
| Rabbits | 5 | 2013 | 278 | 0.190 |
Why?
|
| Molecular Structure | 3 | 2009 | 467 | 0.190 |
Why?
|
| Viral Vaccines | 2 | 2012 | 28 | 0.180 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 1 | 0.180 |
Why?
|
| Cisplatin | 2 | 2023 | 70 | 0.180 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 2 | 0.180 |
Why?
|
| Urinary Bladder | 1 | 2019 | 28 | 0.180 |
Why?
|
| Disease Progression | 3 | 2019 | 580 | 0.180 |
Why?
|
| Cell Line | 4 | 2011 | 1289 | 0.180 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 33 | 0.180 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 5 | 0.180 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 25 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 984 | 0.170 |
Why?
|
| Cell Proliferation | 6 | 2021 | 1149 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 4 | 2015 | 102 | 0.170 |
Why?
|
| Apoptosis | 6 | 2021 | 1317 | 0.160 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 145 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2019 | 118 | 0.160 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 13 | 0.160 |
Why?
|
| Femur Head Necrosis | 1 | 2017 | 1 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2018 | 301 | 0.160 |
Why?
|
| Epitopes | 4 | 2013 | 145 | 0.160 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 122 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 282 | 0.150 |
Why?
|
| Mutagens | 1 | 2017 | 66 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 133 | 0.150 |
Why?
|
| Carcinogens | 1 | 2017 | 117 | 0.150 |
Why?
|
| Papillomavirus E7 Proteins | 3 | 2015 | 11 | 0.140 |
Why?
|
| Male | 11 | 2024 | 18870 | 0.140 |
Why?
|
| Mitochondria | 1 | 2019 | 454 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2009 | 200 | 0.130 |
Why?
|
| Neoplasm Metastasis | 4 | 2018 | 211 | 0.130 |
Why?
|
| Vagina | 2 | 2013 | 81 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 341 | 0.130 |
Why?
|
| Felodipine | 1 | 2014 | 1 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 150 | 0.130 |
Why?
|
| Binding, Competitive | 1 | 2014 | 103 | 0.130 |
Why?
|
| Protein Transport | 2 | 2014 | 286 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 164 | 0.120 |
Why?
|
| Surface Properties | 1 | 2014 | 121 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 32 | 0.120 |
Why?
|
| Piperidones | 1 | 2013 | 9 | 0.120 |
Why?
|
| Metabolomics | 3 | 2019 | 76 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 195 | 0.120 |
Why?
|
| Nogalamycin | 1 | 2013 | 1 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 1530 | 0.120 |
Why?
|
| Cell Death | 1 | 2014 | 260 | 0.120 |
Why?
|
| Digitoxin | 1 | 2013 | 7 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2018 | 386 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2014 | 309 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 168 | 0.110 |
Why?
|
| Cytokines | 2 | 2023 | 569 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2014 | 351 | 0.110 |
Why?
|
| Vaccination | 2 | 2015 | 259 | 0.100 |
Why?
|
| Capsid | 1 | 2011 | 51 | 0.100 |
Why?
|
| Cross Reactions | 2 | 2008 | 83 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 901 | 0.100 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2011 | 108 | 0.100 |
Why?
|
| Peptides | 3 | 2013 | 308 | 0.100 |
Why?
|
| Chalcones | 1 | 2010 | 13 | 0.100 |
Why?
|
| Cottontail rabbit papillomavirus | 1 | 2010 | 1 | 0.100 |
Why?
|
| Human papillomavirus 18 | 1 | 2010 | 5 | 0.100 |
Why?
|
| Plant Extracts | 2 | 2004 | 250 | 0.100 |
Why?
|
| Presenilin-1 | 1 | 2010 | 27 | 0.100 |
Why?
|
| Smoking | 1 | 2017 | 903 | 0.100 |
Why?
|
| Genitalia, Female | 1 | 2010 | 26 | 0.100 |
Why?
|
| Quinazolines | 2 | 2022 | 31 | 0.090 |
Why?
|
| Lythraceae | 1 | 2009 | 3 | 0.090 |
Why?
|
| Xenopus laevis | 1 | 2009 | 73 | 0.090 |
Why?
|
| Proline | 1 | 2009 | 37 | 0.090 |
Why?
|
| Methylation | 1 | 2009 | 102 | 0.090 |
Why?
|
| Tissue Array Analysis | 2 | 2019 | 65 | 0.090 |
Why?
|
| Immunization, Secondary | 1 | 2008 | 8 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2010 | 1442 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2008 | 34 | 0.090 |
Why?
|
| Macaca | 1 | 2008 | 38 | 0.090 |
Why?
|
| Thermodynamics | 1 | 2009 | 207 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 161 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 179 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 242 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 181 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2021 | 54 | 0.080 |
Why?
|
| Vaccines, DNA | 1 | 2007 | 23 | 0.080 |
Why?
|
| Arylalkylamine N-Acetyltransferase | 1 | 2007 | 5 | 0.080 |
Why?
|
| Tumor Virus Infections | 1 | 2007 | 25 | 0.080 |
Why?
|
| Leucine Zippers | 1 | 2007 | 5 | 0.080 |
Why?
|
| COS Cells | 1 | 2007 | 62 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2010 | 897 | 0.080 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 269 | 0.080 |
Why?
|
| Biotinylation | 1 | 2006 | 9 | 0.070 |
Why?
|
| DNA, Viral | 2 | 2007 | 295 | 0.070 |
Why?
|
| Fourier Analysis | 1 | 2006 | 40 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2006 | 60 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2006 | 87 | 0.070 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2007 | 103 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 129 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 445 | 0.070 |
Why?
|
| Phenylephrine | 1 | 2005 | 34 | 0.070 |
Why?
|
| Cadherins | 2 | 2016 | 82 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2005 | 47 | 0.060 |
Why?
|
| Gene Products, tat | 1 | 2004 | 34 | 0.060 |
Why?
|
| Garcinia | 1 | 2004 | 2 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 126 | 0.060 |
Why?
|
| Axonemal Dyneins | 1 | 2024 | 5 | 0.060 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2024 | 5 | 0.060 |
Why?
|
| Forecasting | 1 | 2004 | 124 | 0.060 |
Why?
|
| Temperature | 1 | 2004 | 275 | 0.060 |
Why?
|
| Anacardium | 1 | 2003 | 2 | 0.060 |
Why?
|
| Bleomycin | 1 | 2023 | 18 | 0.060 |
Why?
|
| Templates, Genetic | 1 | 2003 | 22 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 162 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 298 | 0.060 |
Why?
|
| Seeds | 1 | 2003 | 34 | 0.060 |
Why?
|
| Biology | 1 | 2022 | 15 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2023 | 52 | 0.060 |
Why?
|
| Fruit | 1 | 2004 | 159 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 165 | 0.060 |
Why?
|
| Prostate | 1 | 2024 | 136 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2023 | 109 | 0.050 |
Why?
|
| Benzamides | 1 | 2003 | 76 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 834 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 520 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 485 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2022 | 122 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 325 | 0.050 |
Why?
|
| DNA Repair | 1 | 2022 | 181 | 0.050 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 122 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 209 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 35 | 0.050 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 2 | 0.050 |
Why?
|
| Kynurenine | 1 | 2019 | 6 | 0.050 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 1 | 0.050 |
Why?
|
| NADP | 1 | 2019 | 24 | 0.050 |
Why?
|
| Quality of Life | 1 | 2024 | 459 | 0.050 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 10 | 0.050 |
Why?
|
| Nucleotides | 1 | 2019 | 33 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 71 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 135 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 49 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 135 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 62 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 111 | 0.040 |
Why?
|
| Alabama | 1 | 2018 | 46 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 9642 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 247 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 114 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2018 | 63 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2015 | 1802 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 310 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 134 | 0.040 |
Why?
|
| Femur Head | 1 | 2017 | 3 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2017 | 9 | 0.040 |
Why?
|
| Nitrosamines | 1 | 2017 | 9 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 1023 | 0.040 |
Why?
|
| Butanones | 1 | 2017 | 5 | 0.040 |
Why?
|
| Azacitidine | 1 | 2017 | 21 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 424 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2017 | 45 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2017 | 21 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 114 | 0.040 |
Why?
|
| Radiography | 1 | 2017 | 75 | 0.040 |
Why?
|
| DNA Adducts | 1 | 2017 | 41 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2018 | 143 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 186 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 65 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 198 | 0.040 |
Why?
|
| Adult | 3 | 2018 | 11034 | 0.040 |
Why?
|
| Bone Density | 1 | 2017 | 76 | 0.040 |
Why?
|
| Biopsy | 1 | 2017 | 151 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 63 | 0.040 |
Why?
|
| Benzo(a)pyrene | 1 | 2017 | 122 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 195 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2016 | 79 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2016 | 90 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2016 | 116 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 859 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2015 | 59 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 71 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 49 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 66 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 142 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 292 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 727 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 468 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 180 | 0.030 |
Why?
|
| Boronic Acids | 1 | 2013 | 19 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2013 | 24 | 0.030 |
Why?
|
| Pyrazines | 1 | 2013 | 23 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1422 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2013 | 9 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 6 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 859 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2013 | 45 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 41 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 35 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 143 | 0.030 |
Why?
|
| Luciferases | 1 | 2011 | 62 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 480 | 0.030 |
Why?
|
| Immunization | 1 | 2011 | 90 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 650 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 2010 | 29 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 639 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 107 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 171 | 0.020 |
Why?
|
| Bovine papillomavirus 1 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 376 | 0.020 |
Why?
|
| Immune Sera | 1 | 2009 | 59 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 88 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 221 | 0.020 |
Why?
|
| Rats | 2 | 2007 | 3261 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2008 | 42 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 73 | 0.020 |
Why?
|
| Biolistics | 1 | 2007 | 1 | 0.020 |
Why?
|
| Calreticulin | 1 | 2007 | 6 | 0.020 |
Why?
|
| Rhodanine | 1 | 2007 | 2 | 0.020 |
Why?
|
| Acetyl Coenzyme A | 1 | 2007 | 7 | 0.020 |
Why?
|
| Tryptamines | 1 | 2007 | 6 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2007 | 18 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2008 | 61 | 0.020 |
Why?
|
| Papilloma | 1 | 2007 | 15 | 0.020 |
Why?
|
| Pineal Gland | 1 | 2007 | 30 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 818 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 528 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 217 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4012 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 237 | 0.020 |
Why?
|
| Melatonin | 1 | 2007 | 78 | 0.020 |
Why?
|
| Drug Design | 1 | 2007 | 154 | 0.020 |
Why?
|
| United States | 1 | 2016 | 3894 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 350 | 0.020 |
Why?
|
| Skin | 1 | 2007 | 173 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 298 | 0.020 |
Why?
|
| Binding Sites | 1 | 2007 | 597 | 0.020 |
Why?
|
| Urocortins | 1 | 2005 | 4 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 641 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2005 | 9 | 0.020 |
Why?
|
| Cell Size | 1 | 2005 | 42 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 913 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 1681 | 0.020 |
Why?
|
| Base Sequence | 1 | 2005 | 932 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 6448 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 1503 | 0.010 |
Why?
|